v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (7,429,441) $ (13,103,847)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,244,966 1,252,744
Share based compensation 9,712 53,276
Credit loss provision 23,581 (19,316)
Provision to write down inventories to net realizable value 17,934 28,033
Amortization of right of use asset 155,235 173,633
Fair value remeasurement of warrant liability   7,531,044
Fair value remeasurement of contingent forward contract   (899,080)
Fair value remeasurement of contingent value rights   (25,450)
(Gain) loss on extinguishment of debt (332,412) 343,471
Gain on sale of assets (3,700)  
Interest and accretion expense 251,947 212,592
Changes in assets and liabilities:    
Trade and related party accounts receivables 1,027,851 1,601,897
Inventories (124,620) 357,644
Prepaid income taxes 894 (20,847)
Other assets 857,855 534,878
Accounts payable (2,791,040) (489,960)
Accrued compensation and benefits 587,537 403,470
Customer deposits (221,183) (336,485)
Other accrued liabilities 591,228 (496,763)
Accrued interest (130,938) (634,467)
Net cash used in operating activities (6,264,594) (3,533,533)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capital expenditures (2,500) (8,817)
Proceeds from the sale of property, plant and equipment 3,700  
Net cash provided by (used in) investing activities 1,200 (8,817)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Borrowings against related party working capital line of credit 800,000  
Payments against loans payable (881,947) (8,514,664)
Payments against related party loans payable (282,726) (1,038,279)
Payments related to debt issuance costs   (38,613)
Payments related to equity issuance costs (254,359) (2,128,038)
Proceeds from the issuance of common stock under PIPE offering 2,700,700  
Proceeds from the issuance of common stock and pre-funded warrants under registered direct offering   9,690,790
Proceeds from the issuance of common stock on the exercise of pre-funded warrants   11,078
Proceeds from the issuance of Series A and Series B warrants   10,298,134
Proceeds from the issuance of common stock under at-the-market offering 60,604 351,372
Payments for the termination of Series A warrants   (267,391)
Payment of contingent consideration related to acquisition   (2,500,000)
Net cash provided by financing activities 2,142,272 5,864,389
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH (4,121,122) 2,322,039
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD 7,182,344 1,151,348
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD 3,061,222 3,473,387
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:    
Income taxes paid 21,857 49,698
Interest paid 105,249 1,139,593
NONCASH FINANCING AND INVESTING ACTIVITIES:    
Conversion of related party debt to equity $ 1,091,525  
Loss on extinguishment of debt   (343,471)
Issuance of common stock for the settlement of loss contingencies   $ 880,756